Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Very, very interesting analysis from the McSmith blog ...

Judge Davis also recently refused to stay Forgent Networks lawsuit during the patent re-examination (at the request of PUBPAT).

Forgent Announces DVR Patent Lawsuit Update

Court Issues Two Orders Relating to DVR LitigationAUSTIN, TX, Dec 12, 2006 (MARKET WIRE via COMTEX News Network) -- Forgent(TM) Networks (NASDAQ: FORG) -- On Friday, December 8, 2006, the US Federal Court for the Eastern District of Texas issued an order relating to Forgent's infringement contentions in the 6,285,746 patent litigation. In addition, on November 20, 2006, the Court denied a motion to stay the litigation pending the outcome of the US Patent Office reexamination of the patent. "We are pleased that this litigation remains on track for a May 2007 trial," commented Richard Snyder.
Share
New Message
Please login to post a reply